Literature DB >> 2015021

Pulsed methylprednisolone for rheumatoid arthritis.

M D Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2015021      PMCID： PMC1004379          DOI： 10.1136/ard.50.3.202-a

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  5 in total

1.  Fatal acute pyelonephritis following pulsed methylprednisolone for rheumatoid arthritis.

Authors:  D A Walsh; R A Durance
Journal:  Ann Rheum Dis       Date:  1990-11       Impact factor: 19.103

2.  Does steroid pulsing influence the efficacy and toxicity of chrysotherapy? A double blind, placebo controlled study.

Authors:  C S Wong; G Champion; M D Smith; M Soden; M Wetherall; R A Geddes; W R Hill; M J Ahern; P J Roberts-Thomson
Journal:  Ann Rheum Dis       Date:  1990-06       Impact factor: 19.103

Review 3.  Pulse methylprednisolone therapy in rheumatoid arthritis: unproved therapy, unjustified therapy, or effective adjunctive treatment?

Authors:  M D Smith; M J Ahern; P J Roberts-Thomson
Journal:  Ann Rheum Dis       Date:  1990-04       Impact factor: 19.103

4.  The clinical and immunological effects of pulse methylprednisolone therapy in rheumatoid arthritis. I. Clinical effects.

Authors:  M D Smith; J V Bertouch; A M Smith; M Weatherall; M J Ahern; P M Brooks; P J Roberts-Thomson
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666

5.  Pulse steroid therapy in rheumatoid arthritis: can equivalent doses of oral prednisolone give similar clinical results to intravenous methylprednisolone?

Authors:  M D Smith; M J Ahern; P J Roberts-Thomson
Journal:  Ann Rheum Dis       Date:  1988-01       Impact factor: 19.103
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.